The page is the record's research on the issuer — no analyst, no rating, no view. # DataMeds AI, Inc. (NASDAQ: MEDS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing DataMeds AI, Inc. is listed on NASDAQ under the ticker MEDS, with ISIN US9495032057. Its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 78 filings across 61 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-05, is of type corporate_news, and falls 3 days before the record date of 2026-11-08. The NASDAQ exchange median is 6.0 days cadence, 52 filings and 5.0 days latency across 4359 issuers. The sector median is 4.0 days cadence, 70 filings and 3 days latency across 9 issuers. ## Auditor The auditor of record is Suri & Co., Chartered Accountants, located in Bengaluru, India. The record holds one auditor change, dated 2025-11-17. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years 2024, 2025 and 2026 are sealed. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002030763.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/MEDS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/form10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/MEDS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/MEDS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp